Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of aripiprazole in patients with major depressive disorder.

X
Trial Profile

A study of aripiprazole in patients with major depressive disorder.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 02 Feb 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aripiprazole (Primary) ; Antidepressants
  • Indications Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Sponsors Otsuka Pharmaceutical Development & Commercialization
  • Most Recent Events

    • 24 Mar 2014 A post hoc analysis of pooled data from 3 phase 3 studies, was published in Journal of Affective Disorders.
    • 06 Jun 2013 Based on results of this study, and CN138-163 and CN138-139, aripiprazole has received approval from Health Canada as adjunctive treatment of major depressive disorder, according to a Bristol-Myers Squibb media release.
    • 27 May 2010 Results from a pooled analysis (CN138-139, CN138-163 and CN138-165) were reported at the 163rd Annual Meeting of the American Psychiatric Association.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top